title: Tungstate: a potent inhibitor of multifunctional glucose-6-phosphatase.
abstract: The insulin-like action of tungstate in diabetic rats (A. Barberà et al., 1994, J. Biol. Chem. 269, 20047-20053) prompted us to examine the effects of tungstate on the glucose-6-phosphatase system. Our results indicate that tungstate is a potent inhibitor of glucose-6-phosphatase, with a Ki in the 10-25 microM range determined with native microsomes and in the 1-7 microM range determined with detergent-treated microsomes. With both preparations, simple linear competitive inhibition was observed versus glucose 6-phosphate (glucose-6-P) as substrate with the glucose-6-P phosphohydrolase activity of the enzyme. Tungstate was a simple linear competitive inhibitor versus carbamyl phosphate (carbamyl-P) and a linear noncompetitive inhibitor versus glucose with the carbamyl-P:glucose phosphotransferase activity of the glucose-6-phosphatase system. These findings, in addition to the observation that tungstate protected the enzyme against thermal inactivation, indicate that tungstate binds with high affinity and competes at the active site of the enzyme where the substrates glucose-6-P and carbamyl-P bind prior to catalysis. Our results suggest that potent inhibition of glucose-6-P hydrolysis by tungstate is likely responsible, at least in part, for the normalization of glycemia and the rebound in hepatic glucose-6-P levels observed in earlier studies in which tungstate exhibited insulin-like action in diabetic rats.
authors.affiliation: Department of Biochemistry and Molecular Biology, University of North Dakota School of Medicine and Health Sciences, Grand Forks 58203, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Foster
authors.forename: S E
authors.initials: SE
authors.lastname: Young
authors.forename: T D
authors.initials: TD
authors.lastname: Brandt
authors.forename: R C
authors.initials: RC
authors.lastname: Nordlie
mesh_terms: D000818:Animals; D002384:Catalysis; D002463:Cell Membrane Permeability / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D005952:Glucose-6-Phosphatase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D019298:Glucose-6-Phosphate / Q000378:metabolism; D006868:Hydrolysis / Q000187:drug effects; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D010770:Phosphotransferases / Q000378:metabolism; D051381:Rats; D013696:Temperature; D013997:Time Factors; D017973:Tungsten Compounds / Q000494:pharmacology*
chemical_list: D017973:Tungsten Compounds; D019298:Glucose-6-Phosphate; D010770:Phosphotransferases; C026823:carbamylphosphate-D-glucose phosphotransferase; D005952:Glucose-6-Phosphatase; D005947:Glucose; C045951:tungstate